Cash Flow Statement

Amortizatization of Intangibles Capital Expenditures Cash from Financing Activities Cash from Investing Activities Cash from Operations Change in Account Payables Change in Accured Expenses Change in Cash Depreciation & Amortization (CF)Exchange Rate Effect Free Cash Flow Gains from Investment Securities Gains from Sales and Divestitures Net Cash Flow Net Income Non-cash Items Share-based Compensation Shares Issued

Daily Values

Others

Ratios

Moleculin Biotech (MBRX) Acquisitions (2016)

Moleculin Biotech's Acquisitions history spans 1 years, with the latest figure at $99638.0 for Q3 2016.